Reappraisal of immunologic mechanisms of hypomethylating agents in treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia

被引：0
|
作者：
Hong, Junshik
Min, Suji
Park, Jihyun
Fielder, Carly M.
Hu, Qianni
Yoon, Sung-Soo
Kim, Tae Kon
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3269
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting
    Trape, Giulio
    De Angelis, Gioia
    Morucci, Marco
    Tarnani, Michela
    De Gregoris, Cinzia
    Di Veroli, Ambra
    Panichi, Valentina
    Topini, Giuseppe
    Bassi, Loredana
    Isidori, Raffaella
    Poscente, Monica
    Innocenti, Vincenza
    Cippitelli, Elisa Emanueli
    Talucci, Roberta
    Bertelli, Silvia
    Crocicchia, Alessandra
    Lippi, Annalisa
    Pezzuti, Giulia
    Fuschino, Michela
    Randi, Raffaella
    Mastini, Cristina
    Ciambella, Silvia
    Pessina, Gloria
    Montanaro, Marco
    Latagliata, Roberto
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 311 - 317
  • [2] Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
    Simonicova, Kristina
    Janotka, Lubos
    Kavcova, Helena
    Sulova, Zdena
    Breier, Albert
    Messingerova, Lucia
    DRUG RESISTANCE UPDATES, 2022, 61
  • [3] Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes and Myeloid Leukemia
    Szmigielska-Kaplon, Anna
    Robak, Tadeusz
    CURRENT CANCER DRUG TARGETS, 2011, 11 (07) : 837 - 848
  • [4] Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia
    Oosterveld, M
    de Witte, T
    BLOOD REVIEWS, 2000, 14 (04) : 182 - 189
  • [5] Treatment Choices: A Quality of Life Comparison in Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
    Tinsley, Sara M.
    Sutton, Steven K.
    Thapa, Ram
    Lancet, Jeffrey
    McMillan, Susan C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S75 - S79
  • [6] Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
    Ravandi, Farhad
    Issa, Jean-Pierre
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Pierce, Sherry
    Shan, Jianqin
    Borthakur, Gautam
    Verstovsek, Srdan
    Faderl, Stefan
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2009, 115 (24) : 5746 - 5751
  • [7] Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Zavras, Phaedon D. D.
    Sinanidis, Ilias
    Tsakiroglou, Panagiotis
    Karantanos, Theodoros
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [8] Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
    Kang, Ka-Won
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Choi, Chul Won
    Park, Yong
    Kim, Byung Soo
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [9] Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directions
    Short, Nicholas J.
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : 1616 - 1626
  • [10] Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome
    Mabrey, Frances Linzee
    Gardner, Kelda M.
    Dorcy, Kathleen Shannon
    Perdue, Andrea
    Smith, Heather A.
    Davis, Alicyn M.
    Hammer, Cody
    Rizzuto, Donelle
    Jones, Sunny
    Quach, Kim
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    Becker, Pamela S.
    BLOOD ADVANCES, 2020, 4 (04) : 611 - 616
12345